Vincent Roy

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Escherichia Coli

Multidrug Resistant

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Hervin, Vincent Roy, Luigi A Agrofoglio
Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target. Molecules (Basel, Switzerland) 28 (24) (2023)
Vincent Hervin, Vincent Roy, Luigi A Agrofoglio
Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target. Molecules (Basel, Switzerland) 28 (24) (2023)
Nicolas G Biteau, Vincent Roy, Cyril Nicolas, Hubert F Becker, Jean-Christophe Lambry, Hannu Myllykallio, Luigi A Agrofoglio
Synthesis and Structure-Activity Relationship Studies of Pyrido [1,2- e ]Purine-2,4( 1H,3H )-Dione Derivatives Targeting Flavin-Dependent Thymidylate Synthase in Mycobacterium tuberculosis . Molecules (Basel, Switzerland) 27 (19) (2022)
Tuniyazi Abuduaini, Vincent Roy, Julien Marlet, Catherine Gaudy-Graffin, Denys Brand, Cécile Baronti, Franck Touret, Bruno Coutard, Tamara R McBrayer, Raymond F Schinazi, Luigi A Agrofoglio
Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs. Molecules (Basel, Switzerland) 26 (5) (2021)
Vincent Hervin, Ritu Arora, Jyoti Rani, Srinivasan Ramchandran, Urmi Bajpai, Luigi A Agrofoglio, Vincent Roy
Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of Mycobacterium tuberculosis Mur Ligases. Molecules (Basel, Switzerland) 25 (21) (2020)